UNSPSC 85815722: Introduction of clofarabine into central vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of clofarabine into central vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0430P

UNSPSC 85815722 Introduction of clofarabine into central vein, percutaneous approach is a Commodity code that captures a chemotherapy administration procedure, yet the recent opportunities tagged to this code show little alignment with the nominal scope. State and local government solicitations under this code over the past two months reflect broad healthcare service procurement—telehealth urgent care, occupational health screening, cancer registry operations, psychiatric evaluation, EMS staffing, and opioid use disorder treatment—rather than inpatient oncology infusion services. The issuing bodies span state departments, counties, cities, school districts, and special-purpose health authorities across California, Georgia, Nevada, Colorado, Florida, Kansas, Missouri, and Texas. No single jurisdiction dominates recent activity; the code sees light, scattered use across multiple states and procurement types, with RFPs, RFQs, and IFBs all present.

Representative recent opportunities illustrate the scope mismatch. The Inland Empire Health Plan issued an RFI (October 31, 2026 response date) for virtual urgent care services delivered by California-licensed physicians to plan members in San Bernardino County—telehealth-based medication management and clinical evaluation, not oncology procedures. The Nevada Health Authority posted an RFP for Program of All Inclusive Care for the Elderly (PACE) operations (proposals due December 10, 2026), encompassing multidisciplinary care for seniors, including physician services, therapies, and assisted living, across three service areas at fixed capitation rates ranging from $4,532.24 to $8,804.32 per participant monthly. The County of San Mateo issued solicitations for cancer registry services (RFP 660002627262, due October 12, 2026) and handheld retinal screening devices and services (RFP 660002627264, due November 6, 2026), both focused on ambulatory care workflow support rather than inpatient chemotherapy administration. The code shows minimal recent activity aligned to its clinical definition, signaling either classifier error in the procurement postings or low state and local procurement volume under this specific code tier.